In the best-case scenario, the patient requests a drug that is appropriate for her condition. But if the patient asks for an inappropriate drug, the doctor may give in and prescribe it, potentially endangering the patient's health. Also, the patient and doctor "can get locked in an argument that imperils the doctor-patient relationship." Despite the lack of information found in most direct-to-consumer drug ads, their proponents often cite patient education as a reason for why the U.S. should allow such ads--despite the fact that no other English-speaking country does. "The medical community should exert pressure on the drug industry to incorporate more information about conditions and treatments in its advertising," the team writes. "If such information is not provided voluntarily by the industry in future advertising, the medical establishment should lobby for regulation."